Spire Wealth Management’s Insmed INSM Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q3
$87.4K Hold
766
– – ﹤0.01% 981
2026
Q2
$81.7K Buy
766
+1
+0.1% +$121 ﹤0.01% 1034
2026
Q1
$125K Hold
765
– – ﹤0.01% 920
2025
Q4
$133K Sell
765
-12
-2% -$2.19K ﹤0.01% 908
2025
Q3
$112K Buy
777
+80
+11% +$9.8K ﹤0.01% 950
2025
Q2
$70.1K Buy
697
+12
+2% +$918 ﹤0.01% 1096
2025
Q1
$52.3K Hold
685
– – ﹤0.01% 1263
2024
Q4
$47.3K Buy
+685
New +$49.3K ﹤0.01% 1309
2022
Q1
– Sell
-993
Closed -$27K – 2689
2021
Q4
$27K Buy
+993
New +$28.4K ﹤0.01% 2008
2021
Q2
– Sell
-993
Closed -$34K – 2765
2021
Q1
$34K Buy
+993
New +$38K ﹤0.01% 1919

Other funds holding INSM

Spire Wealth Management's INSM Position: Q3 2026 in Review

Spire Wealth Management held its Insmed (INSM) position steady in Q3 2026 at 766 shares worth $87.4K. The position accounts for ﹤0.01% of the portfolio, ranked #981.

Spire Wealth Management first reported a position in INSM in Q1 2021 and has held it in 10 quarters since. The position peaked at $133K in Q4 2025. 706 funds tracked by Wall St. Rank hold INSM as of Q3 2026.

  • Spire Wealth Management held 766 shares of Insmed worth $87.4K as of Q3 2026.
  • Spire Wealth Management left its Insmed share count unchanged in Q3 2026.
  • Insmed made up ﹤0.01% of Spire Wealth Management's portfolio in Q3 2026, its #981 holding.
  • Spire Wealth Management first reported a position in Insmed in Q1 2021 and has held it in 10 quarters since.
  • Spire Wealth Management's Insmed position peaked at $133K in Q4 2025.
  • 706 funds tracked by Wall St. Rank held Insmed as of Q3 2026.

Based on Spire Wealth Management's 13F filing for Q3 2026, filed 30 Oct 2026.